Mounjaro 12.5 mg Pen

Product Description

Mounjaro is a once-weekly, subcutaneous injection that contains tirzepatide, a dual GIP/GLP-1 receptor agonist. The 12.5 mg strength is commonly used as the third dose. The pre-filled, single-use pen is designed for at-home administration with a simple, discreet injection experience when used exactly as prescribed - 1 Pen